Radiation Injuries Clinical Trial
— MRCCLOfficial title:
Novel Wireless Mixed Reality Headset for Image Guidance in Cardiac Catheterization Laboratory
NCT number | NCT05063773 |
Other study ID # | HUD_002 |
Secondary ID | |
Status | Not yet recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | March 2023 |
Est. completion date | March 2024 |
Verified date | September 2021 |
Source | SG Devices LLC |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Our hypothesis is that improved line of sight to patient data, ergonomics, and headset lead shielding in the CCL will lead to behavioral changes in the CCL personnel that will reduce radiation exposure to all members of the team. Further, reducing the burden of large, cumbersome monitors will enable improved use of shielding. Our approach is a single center randomized controlled trial of consecutive patients randomly assigned to one of two groups with group 1 using mixed reality display and group 2 using standard 2D displays to perform diagnostic angiography in the CCL. Radiation exposure will be evaluated at multiple levels including total radiation exposure, exposure of each individual staff member, as well as specific exposure to eyes and head in group 1 versus group 2.
Status | Not yet recruiting |
Enrollment | 150 |
Est. completion date | March 2024 |
Est. primary completion date | March 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - undergoing diagnostic coronary angiography Exclusion Criteria: - acute coronary syndrome, cardiogenic shock, cardiac arrest, planned intervention |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
SG Devices LLC | National Institutes of Health (NIH), University of Minnesota |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Radiation exposure to the physician | up to 24 months | ||
Secondary | radiation exposure to the patient and medical staff | up to 24 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04059809 -
Photobiomodulation for Breast Cancer Radiodermatitis
|
Phase 2/Phase 3 | |
Completed |
NCT02985164 -
Radiation Exposure During Endoscopic Retrograde Cholangiopancreatography
|
Phase 3 | |
Recruiting |
NCT04152681 -
Effect and Safety of Apatinib on Radiation-Induced Brain Injury
|
Phase 2 | |
Recruiting |
NCT04818099 -
Vortioxetine in the Treatment of Depression Associated With Head and Neck Cancers Undergoing Radiotherapy
|
Phase 3 | |
Completed |
NCT03667859 -
Vaginal Elasticity Assessment Before and After Brachytherapy/Pelvic Radiation
|
||
Terminated |
NCT03660618 -
LSFG-SKIN, Laser Speckle Flowgraphy
|
N/A | |
Completed |
NCT00725244 -
Trial of Endoscopy Bipolar and Argon of Chronic Rectal Bleeding From Radiation Telangiectasias
|
Phase 4 | |
Completed |
NCT00001523 -
Structure and Functional Status of Parotid Glands Exposed to Therapeutic Irradiation
|
N/A | |
Recruiting |
NCT03907371 -
The Effect of Donepezil in Radiotherapy-related Cognitive Impairment.
|
Phase 2 | |
Completed |
NCT00001437 -
Trial of Pentoxifylline in Patients With Functional Disability Caused by Radiation-Induced Advanced Regional Fibrosis
|
Phase 2 | |
Recruiting |
NCT06325982 -
Clinical Observation of Drug Retention Enema in Preventing Acute Radiation-induced Rectal Injury
|
N/A | |
Recruiting |
NCT03208413 -
The Therapeutic Effect of Thalidomide in RI
|
Phase 2 | |
Completed |
NCT02972736 -
RadiatiOn Dose Among Different EndOvascular Procedures: the RODEO Study
|
||
Completed |
NCT02104271 -
Comparison Between Two Different Parameters of Argon Plasma Coagulation in the Treatment of Chronic Radiation Proctitis: Historical Control Trial.
|
Phase 2 | |
Terminated |
NCT00134628 -
Study to Determine if Hyperbaric Oxygen Therapy is Helpful for Treating Radiation Tissue Injuries
|
Phase 3 | |
Completed |
NCT03961217 -
Return to Work Among Cancer Survivors With Treatment-induced Survivorship Syndromes
|